Exponent, Inc. (NASDAQ:EXPO) Shares Sold by Avantax Advisory Services Inc.

Avantax Advisory Services Inc. trimmed its position in shares of Exponent, Inc. (NASDAQ:EXPO) by 5.4% during the fourth quarter, HoldingsChannel reports. The fund owned 18,884 shares of the business services provider’s stock after selling 1,076 shares during the quarter. Avantax Advisory Services Inc.’s holdings in Exponent were worth $1,683,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in EXPO. Raymond James Financial Inc. purchased a new position in shares of Exponent during the 4th quarter worth approximately $55,131,000. JPMorgan Chase & Co. boosted its position in shares of Exponent by 63.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock worth $72,701,000 after purchasing an additional 245,086 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Exponent by 4.8% during the 3rd quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider’s stock worth $173,597,000 after purchasing an additional 69,099 shares during the period. Barclays PLC increased its holdings in shares of Exponent by 219.0% in the 3rd quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock valued at $11,127,000 after purchasing an additional 66,263 shares in the last quarter. Finally, TimesSquare Capital Management LLC lifted its stake in shares of Exponent by 22.4% in the fourth quarter. TimesSquare Capital Management LLC now owns 342,850 shares of the business services provider’s stock valued at $30,548,000 after purchasing an additional 62,760 shares during the period. 92.37% of the stock is owned by hedge funds and other institutional investors.

Exponent Trading Up 0.4 %

Shares of Exponent stock opened at $83.02 on Tuesday. The company has a 50-day moving average of $88.45 and a two-hundred day moving average of $97.18. Exponent, Inc. has a 12-month low of $77.30 and a 12-month high of $115.75. The stock has a market cap of $4.22 billion, a PE ratio of 39.16 and a beta of 0.77.

Exponent (NASDAQ:EXPO) last issued its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same quarter in the previous year, the firm earned $0.41 earnings per share. On average, sell-side analysts forecast that Exponent, Inc. will post 1.98 EPS for the current fiscal year.

Insider Buying and Selling

In other Exponent news, VP Richard Reiss sold 1,736 shares of Exponent stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the completion of the transaction, the vice president now owns 1,800 shares in the company, valued at approximately $154,674. The trade was a 49.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 2.10% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.